PHusis Therapeutics, Inc.
PrivateLast Round
Accelerator
Nov 1, 2022
Total Funding Raised
$3.63M
Company Overview
PHusis Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in November 2022.
PHusis Therapeutics, Inc. is a biotechnology company that develops targeted small molecule therapeutics by blocking the pleckstrin homology (PH)-domain of critical signaling proteins involved in cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PHusis Therapeutics, Inc. Comparables
Compare PHusis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontier Medicines | 77% | |
| Machavert Pharmaceuticals | 76% | |
| Erasca | 76% |
For institutional investors. Book with your work email.
PHusis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 1, 2022 | ||||
| Grant | May 13, 2020 | ||||
| Grant | Jan 12, 2018 | ||||
| Grant | Jul 15, 2014 | ||||
| Grant | Aug 1, 2013 |
For institutional investors. Book with your work email.
PHusis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| University of Arizona Center for Innovation | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2022
University of Arizona Center for Innovation participated in the round.
- May 13, 2020
$414K grant received from the National Cancer Institute.
For institutional investors. Book with your work email.
PHusis Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PHusis Therapeutics, Inc.'s valuation, stock price, and market status.
Is PHusis Therapeutics, Inc. a public or private company?
PHusis Therapeutics, Inc. is a private company.
What is the current stock price of PHusis Therapeutics, Inc.?
PHusis Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks PHusis Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PHusis Therapeutics, Inc. worth (valuation)?
Valuation information for PHusis Therapeutics, Inc. is not publicly available.
Can I buy PHusis Therapeutics, Inc. stock?
PHusis Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PHusis Therapeutics, Inc.'s last funding round?
PHusis Therapeutics, Inc.'s most recent funding round was Accelerator on November 1, 2022.
Who are the main investors in PHusis Therapeutics, Inc.?
Key investors in PHusis Therapeutics, Inc. include National Cancer Institute, University of Arizona Center for Innovation, National Institutes of Health (NIH).
Will PHusis Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for PHusis Therapeutics, Inc..
How can I track PHusis Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PHusis Therapeutics, Inc.'s shares on secondary markets.